EMEA-003563-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 13:30
EMEA-003563-PIP01-23
EMEA-003390-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 13:22
EMEA-003390-PIP01-23
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 11 June 2025 - 13:10
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 2, Status: Authorised
EMEA-003562-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 13:01
EMEA-003562-PIP01-23
EMEA-003561-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 12:48
EMEA-003561-PIP01-23
EMEA-003559-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 12:38
EMEA-003559-PIP01-23
EMEA-003557-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 12:24
EMEA-003557-PIP01-23
EMEA-003555-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 12:11
EMEA-003555-PIP01-23
EMEA-003554-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 11:03
EMEA-003554-PIP01-23
EMEA-003552-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 11:00
EMEA-003552-PIP01-23